SalioGen Therapeutics
Timothy D. McKee is an accomplished professional in the field of biochemistry, currently serving as Associate Director of BioAnalytical Development at SalioGen Therapeutics since July 2024. McKee has held significant roles in various organizations, including Principal Scientist at Frontera Therapeutics from September 2021 to June 2023, and Senior Research Scientist at BioAgilytix from January 2020 to September 2021. Previous experience includes serving as Analytical Project Lead at Takeda, and as a Senior Scientist at Rodin Therapeutics. McKee began a career in research as a Senior Research Investigator at Satori Pharmaceuticals, where innovative work led to advancements in gamma secretase modulators. With a Ph.D. in Biochemistry from Brandeis University and a B.S. in Chemistry from Ithaca College, McKee brings a strong academic background to a rich professional history spanning over three decades.